It has been a miserable decade for emerging market (EM) investors, says David Thorpe in FT Adviser. EM shares have returned just a third as much as the global average. And recent performance has not been encouraging: the combined market capitalisation of the 24-country MSCI Emerging Markets index has fallen $4trn since early 2021, say Srinivasan Sivabalan and Karl Lester Yap on Bloomberg. Rising US interest rates and slowing global growth are weighing heavily on the asset class.
EMs don’t look expensive now, but the US dollar is the sector’s “puppet master”, James Sullivan of Tyndall Investment Management tells FT Adviser. “Ascertaining the true value of a market that is intrinsically linked to a foreign currency is fraught with jeopardy.” A strong dollar makes it more expensive for businesses that borrow in dollars but earn in local currency to service their debts. There are plenty of those in emerging markets. “US dollar credit to non-banks outside the US stands at $12.6trn, which represents 14.8% of world GDP, up from less than 10% in 2007.”
The dollar could easily go higher from here and that may make for a “rather unpleasant outcome”. And it’s not just companies that need to worry about debt. Emerging market sovereigns have increased their borrowing to 67%, up from 52% pre-pandemic, says The Wall Street Journal. Now the bill for the borrowing binge is coming due. “Interest expenses as a percentage of government revenue, at some 10%, are the highest since before the 2007-2008 panic.” That set-up has triggered “countless emerging-market crises” in the past.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Learning the lessons
On the plus side, central banks and governments in most emerging economies have learnt their lessons from previous crises and look well prepared to cope with a period of dollar strength, says Kimberley Sperrfechter of Capital Economics.
Yes, there are a few countries with “fragile external positions” (meaning they rely on foreign investors to fund their trade deficits), such as Turkey, Chile and “a handful of central European economies”. However, they are the exceptions in the EM universe.
In any case, not all emerging markets are doing badly. Commodity currencies such as the Brazilian real and South African rand have performed well this year. Global investors have been piling into Indonesia, says Dave Sebastian in The Wall Street Journal: foreign institutions pumped $5bn into local equities between January and April, even as they pulled funds from elsewhere in emerging Asia. “Indonesia is the world’s largest coal exporter and a producer of other key commodities such as oil, gas, nickel and palm oil.”
This hints at a dilemma for investors. “Emerging market indices are dominated by a handful of larger markets,” says Theo Andrew on ETF Stream.
In particular, China accounts for more than 30%, leaving any fund that tracks the overall asset class exposed to the whims of Beijing. Index providers have started to roll out emerging markets ex-China products, but investors want to go further and move towards “different themes within emerging markets” rather than simple country classifications.
For more on this topic see:
The easy way to invest in emerging markets
Emerging-market investors turn cautious
-
How to invest in nuclear powerWe need nuclear power to go green, says Dominic Frisby. But there is a better option than huge power stations
-
Chase slashes its easy-access savings rate – is it time to switch?The Chase easy-access savings account has proved popular with savers thanks to its competitive rate and bonus deals. But, as the rate has dropped, has it lost its charm?
-
Pfizer shares rise as US investor takes $1 billion stakePfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
-
Qualcomm could acquire rival Intel – but securing the deal won't be easyA tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
-
How to invest in the quiet market monthsHere's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
-
Spire Healthcare: invest in the booming demand for private healthcareSpire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
-
Are insurance companies a good investment?Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
-
Google's legal challenges – could it be broken up?Google is fending off legal challenges from both the EU and the US. But would breaking it up actually work?
-
Fast-growing bargain stocks the market has missedA professional investor recommends attractive stocks to invest in. This week: Dan Higgins, portfolio manager, Majedie Investments, highlights three favourites
-
Are matchboxes worth collecting?TikTok is reigniting a spark for matchbox collecting. Is there any value in phillumeny or will it fizzle out?
